JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M909219199 on March 15, 2000

J. Biol. Chem., Vol. 275, Issue 22, 17051-17057, June 2, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/22/17051    most recent
M909219199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iyer, S.
Right arrow Articles by Buelow, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iyer, S.
Right arrow Articles by Buelow, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of Tumor Necrosis Factor mRNA Translation by a Rationally Designed Immunomodulatory Peptide*

Suhasini IyerDagger §, Dimitris Kontoyiannis, Dominique ChevrierDagger , Jacky WooDagger , Nancy MoriDagger , Marie CornejoDagger , George Kollias, and Roland BuelowDagger

From Dagger  SangStat, The Transplant Company, Fremont, California 94555 and the  Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens 11521, Greece

Based on sequences of immunomodulatory peptides derived from the heavy chain of HLA Class I, novel immunomodulatory peptides with increased potency were developed by computer-aided rational design. Allotrap 1258 was characterized in detail and shown to inhibit cell-mediated immune responses in vitro and in vivo. Immunomodulatory activity was associated with the capability of the peptides to modulate heme oxygenase (HO) activity. In this study we analyzed the effect of Allotrap 1258 on cytokine expression. Allotrap 1258 inhibited concanavalin A- and lipopolysaccharide-induced human and mouse tumor necrosis factor (TNF) production in vitro and in vivo but had no effect on interleukin (IL)-1, IL-2, IL-4, IL-6, or IL-10 expression. Experiments with HO-1/KO and iNOS/KO mice showed that Allotrap 1258-mediated inhibition of TNF was independent of HO-1 and iNOS. Quantitation of TNF protein expression and mRNA steady state levels demonstrated that Allotrap 1258-mediated inhibition occurred at the translational level. Deletion of the AU-rich element in the 3'-untranslated region (UTR) of TNF mRNA, a region known to be involved in TNF mRNA translation, had minimal effect on Allotrap 1258-mediated inhibition. However, replacement of the TNF 3'-UTR with the human globin 3'-UTR rendered the peptide inactive. This demonstrates that besides AU-rich elements, other sequences in the 3'-UTR of TNF mRNA are involved in translational control of TNF expression. Such sequences are necessary for Allotrap 1258-mediated inhibition of TNF production.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: SangStat, The Transplant Company, 6300 Dumbarton Circle, Fremont, CA 94555. Tel.: 510-789-4508; Fax: 510-789-4206; E-mail: siyer@sangstat.com.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
W. Zang, S. Kalache, M. Lin, B. Schroppel, and B. Murphy
MHC Class II-Mediated Apoptosis by a Nonpolymorphic MHC Class II Peptide Proceeds by Activation of Protein Kinase C
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3661 - 3668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Y. Zhang, X. D. Zhang, J. M. Borrow, T. Nguyen, and P. Hersey
Translational Control of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Death Receptor Expression in Melanoma Cells
J. Biol. Chem., March 12, 2004; 279(11): 10606 - 10614.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Galban, J. Fan, J. L. Martindale, C. Cheadle, B. Hoffman, M. P. Woods, G. Temeles, J. Brieger, J. Decker, and M. Gorospe
von Hippel-Lindau Protein-Mediated Repression of Tumor Necrosis Factor Alpha Translation Revealed through Use of cDNA Arrays
Mol. Cell. Biol., April 1, 2003; 23(7): 2316 - 2328.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R Boismenu, Y Chen, K Chou, A El-Sheikh, and R Buelow
Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis
Ann Rheum Dis, November 1, 2002; 61(90002): ii19 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. MacKenzie, N. Fernandez-Troy, and E. Espel
Post-transcriptional regulation of TNF-{alpha} during in vitro differentiation of human monocytes/macrophages in primary culture
J. Leukoc. Biol., June 1, 2002; 71(6): 1026 - 1032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.